Previous studies have discovered that HHLA2 is overexpressed in gastric cancer, osteosarcoma, clear cell renal cell carcinoma, bladder urothelial cancer, and HCC and is associated with a poor prognosis (8–11). The gene discussed is HHLA2; the disease is hepatocellular carcinoma.